The recession is over, if sales of cosmetic drugs and surgeries in Q4 2009 are to be believed. Beauty procedures -- such as Botox and breast implants -- were up during the last three months of the year, according to Leerink Swann's MEDACorp survey panel. The increase is the first since 2007:
... procedures for botulinum toxins like Allergan's (AGN) Botox and facial fillers like Medicis Pharmaceutical's (MRX) Restylane increased the most year-over-year in the fourth quarter of 2009, each up 8.1%. Procedures for breast implants increased 3.5% and laser work was up 1.6%.The results were reflected in Allergan's Q4 earnings, too. Revenue at the Botox-maker was up from $4.4 billion to $4.5 billion. Here's a breakdown of sales of their individual products:
- Brand: Sales in Q4'09, Q4'08 Botox: 347.7, 329.2 Skin care: 64.5, 32.7 Breast aesthetics: 77.8, 70.9 Facial Aesthetics: 66.0, 55.8 Latisse: 26.0, NA
- Source: Company disclosures.
Image via Flickr user Axel Hecht, CC.
for more features.